Impact of COVID-19 lockdown on progressive multiple sclerosis patients

9Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: The COVID-19 pandemic caused major changes in the lifestyle and in the access to health services worldwide.Progressive multiple sclerosis (pMS) patients are a vulnerable population at high risk of disability worsening. Objective and Methods: The objective of this study was to assess the health outcomes of COVID-19 lockdown in a cohort of 225 pMS patients. Results: Worsening of neurological disability (19.7%) and fatigue (32.4%), depression (30.4%), and weight increase (28.3%) were observed in pMS patients during lockdown, along with discontinuation of regular physical exercise (47.1%) and of physical therapy (59.3%). Conclusion: These results highlight the adverse impact, on pMS patients, of the public health measures implemented for the containment of the pandemic.

Cite

CITATION STYLE

APA

Vercellino, M., Bosa, C., Alteno, A., Schillaci, V., Petracca, M., Marasciulo, S., & Cavalla, P. (2022). Impact of COVID-19 lockdown on progressive multiple sclerosis patients. Neurological Sciences, 43(5), 2943–2946. https://doi.org/10.1007/s10072-022-05909-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free